Noopept user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: Noopept dosage in studies.

In short

Of 90 people, 59 (66%) said Noopept brought some benefit and 26 (29%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Nootropics (78 accounts), r/Biohackers (16) and r/noopept (8), 18 Oct 2024 to 10 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about Noopept, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 29/30 (97%). One post looked like marketing and is not in the figures.

Whose accounts these are: routes mentioned: nasal spray 12, by mouth 8, under the tongue 8; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did Noopept help? The overall picture

Of 90 people, 43 (48%) reported benefit only, 16 (18%) both benefit and harm, 10 (11%) harm only and 21 (23%) neither.

Stopping. 11 people (12%) said they stopped or paused: 4 because of harms and 7 because they noticed no effect or for another reason.

Share = people / 90.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only4348%
Both benefit and harm1618%
Harm only1011%
Neither benefit nor harm2123%

Most common reported benefits

Of 90 people. 59 (66%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Focus or thinking3033%
Alertness or motivation1719%
Better mood1112%
Less anxiety78%
Memory67%
Word finding or speech44%
Other benefit2831%

Share = people / 90.

Most common reported harms

Of 90 people. 26 (29%) mentioned some harm; 1 said explicitly they had none.

ReportedPeopleShare
Insomnia67%
Anxiety, restlessness or irritability56%
Fatigue56%
Emotional blunting or low mood33%
Brain fog22%
Nausea or stomach upset22%
Headache22%
Other, rarer harm1112%

Share = people / 90.

How severe were the harms?

Of the 25 people who described how strong a harm was, 19 (76%) described it as mild, 6 (24%) as clearly bothersome and 0 (0%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 25.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable1976%
Clearly bothersome: several days, sleep or work affected624%
Severe: emergency visit, hospital or unable to function00%

Harms known from research and regulators: What are the side effects of Noopept?

How long did people use Noopept?

33 of 90 people (37%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 33.
Stated length of usePeopleShare
Under a week1855%
1-4 weeks721%
1-3 months515%
Over 3 months39%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

44 of 90 people (49%) used other substances at the same time. The most common: alpha-GPC (18), caffeine (12) and phenylpiracetam (12). Then the account cannot tell which substance had the effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: Noopept dosage in studies. Legal status: Is Noopept legal in Finland?

What can be concluded?

The most common reported benefit was focus, and harms were reported less often than benefits; the most common of them was insomnia. Many noticed nothing, and feelings like these are especially open to placebo effects.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: Noopept: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Semax user experiences, Selank user experiences, DSIP user experiences, Semax + Selank blend user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.